A trial-based economic evaluation of peppermint oil for the treatment of irritable bowel syndrome

Z.Z.R.M. Weerts*, B.A.B. Essers, D.M.A.E. Jonkers, J.I.A. Willems, D.J.P.A. Janssen, B.M. Witteman, C.H.M. Clemens, A. Westendorp, A.A.M. Masclee, D. Keszthelyi

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Web of Science)
Original languageEnglish
Number of pages10
JournalUnited European Gastroenterology Journal
DOIs
Publication statusE-pub ahead of print - 1 Sep 2021

Keywords

  • Abdominal pain
  • cost-effectiveness
  • economic burden
  • ICER
  • irritable bowel syndrome
  • peppermint oil
  • QALY
  • COST-EFFECTIVENESS ANALYSIS
  • QUALITY-OF-LIFE
  • EFFICACY
  • IMPACT
  • 12-WEEK
  • IBS

Cite this